Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas à cause du BNP?

Naveen L Pereira, Viral K Desai, Allan S Jaffe

Journal: European journal of heart failure 2020;21(5):609-612

PMID: 30834697

Free Full Text on PubMed Central View on PubMed

Abstract

Address: Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.; Division of Core Clinical Laboratory Service, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

DOI: 10.1002/ejhf.1451

Link outs

Free resources

Full Text Sources:

https://pmc.ncbi.nlm.nih.gov/articles/pmid/3083469...
https://europepmc.org/abstract/MED/30834697
https://onlinelibrary.wiley.com/doi/10.1002/ejhf.1...

Medical:

https://medlineplus.gov/heartfailure.html

MeSH Terms: Aminobutyrates, Biphenyl Compounds, Drug Combinations, Heart Failure, Humans, Natriuretic Peptides, Neprilysin, Tetrazoles, Valsartan